CB-Naat positive

44-year-old male, stigmata of HIV, presented with shortness and respiratory distress. Patient was intimated and sedated. The patient is a known MDR-TB patient, on further investigation found to have completed treatment in 2015. Other history was not obtained. On arrival patient x/ray reviewed (attached - Image 1) and bilateral infiltrates noted as well as ? right lung mass. The patient sent for urgent non-contrast CTB (NAD) and chest. CT findings: ‘Basal infiltrates bilaterally, no cavities, faint effusions with no gross adenopathy. Active TB is very unlikely. Cardiomegaly with PAH. Paraseptal emphysema - mild degree only. Right pericardiac mass (mediastinal).” Patient management is ongoing. What are your valuable suggestions?

COVID-19?? 68 year old male with no significant past medical history or surgical history. Presented with shortness of breath, and chest pain. In the emergency department, the patient has a saturation of 79% on room air and is in Moderat respiratory distress. It requires 10 L of nasal oxygen high flow to obtain 93% oxygen saturation. The patient is also febrile to 101°F. Social history: non-smoker, non-drinker. Surgical history: no surgical history. What do you say about the case?

24/m c/o breathlessness,sore throat.has history of travel from lko 7 days back.what could be the diagnosis

Middle aged male presented with fever last 3 days ago. Then over next 2 days no fever. No history of cough. CBC normal Spo2 96% HR 105 Bp 160/90 As a routine protocol cxray done showed left basal heziness and then CT thorax done. Plz comment on further management approach

Coronavirus breakthrough as scientists discover Drug used to treat HEAD LICE can kill COVID-19 cells #CCU_CORONA =================================== updated 02:46 04 Apr 2020 Researchers at Monash University found Ivermectin can kills COVID-19 cells The anti-parasite drug killed off the cells within two days and is widely available Scientists are moving towards human trials but expect it to be at least a month Ivermectin has also been found to work against HIV, influenza and Zika virus An anti-parasitic head lice drug available around the world has been found to kill COVID-19 in the lab within 48 hours. A Monash University-led study has shown a single dose of the drug Ivermectin could stop the SARS-CoV-2 virus growing in cell culture. 'We found that even a single dose could essentially remove all viral RNA (effectively removed all genetic material of the virus) by 48 hours and that even at 24 hours there was a really significant reduction in it,' Monash Biomedicine Discovery Institute's Dr Kylie Wagstaff said on Friday. While it's not known how Ivermectin works on the virus, the drug likely stops the virus dampening the host cells' ability to clear it. The next step is for scientists to determine the correct human dosage, to make sure the level used in vitro is safe for humans. https://www.dailymail.co.uk/news/article-8186287/Monash-University-scientists-anti-parasite-Ivermectin-kill-COVID-19-cells-two-days.html